Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vanycomycin in Adults With Primary Sclerosing Cholangitis

NCT03710122 is registered in ClinicalTrials.gov with Elizabeth Carey as lead sponsor.

NCT NCT03710122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03710122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vanycomycin in Adults With Primary Sclerosing Cholangitis
Lead sponsor
Elizabeth Carey
Phase
Phase 2/3
Overall status
Terminated
Start date
January 23, 2020
Completion date
March 20, 2025
Enrollment
102 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

primary sclerosing cholangitis